Avidity Biosciences Inc (RNA)

31.04 -0.31 (-0.99%) USD  |  NASDAQ  |  Dec 26, 13:11
More

Avidity Biosciences Cash and Short Term Investments (Quarterly): 1.589B for Sept. 30, 2024

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for RNA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Short Term Investments Definition

View Cash and Short Term Investments Definition
Start Trial

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Vertex Pharmaceuticals Inc 6.524B
Sarepta Therapeutics Inc 1.198B
Dyne Therapeutics Inc 723.67M
Entrada Therapeutics Inc 449.34M
Catalyst Pharmaceuticals Inc 442.33M